ArticlePloS one2025

KYLO-0603, a novel liver-targeting, thyroid hormone receptor-β agonist for the inhibition of MASH progression.

Xueqin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.